Small increase in dolutegravir trough, but equivalent total dolutegravir exposure with simeprevir in HIV/HCV seronegative volunteers | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Small increase in dolutegravir trough, but equivalent total dolutegravir exposure with simeprevir in HIV/HCV seronegative volunteers

MacBrayne CE, Castillo-Mancilla J, Burton, Jr JR, et al. Small increase in dolutegravir trough, but equivalent total dolutegravir exposure with simeprevir in HIV/HCV seronegative volunteers. Antimicrob Chemother. 2018;73(1):156-159.

Publication Type:

Journal Article

Authors:

MacBrayne, CE; Castillo-Mancilla, J; Burton, James R. Jr; et, al

Source:

Antimicrob Chemother, Volume 73, Issue 1, p.156-159 (2018)

Cited On:

Export Citation:

RIS Format

Top